Several COVID-19 convalescents suffer from the post-acute COVID-syndrome (PACS)/long
COVID, with symptoms that include fatigue, dyspnea, pulmonary fibrosis, cognitive …

The immune response in patients with Coronavirus Disease 2019 (COVID-19) is highly
variable and is linked to disease severity and mortality. However, antibody and cytokine …

Spleen tyrosine kinase (SYK) is a previously unidentified therapeutic target that inhibits
neutrophil and macrophage activation in coronavirus disease 2019 (COVID-19) …

Background: As the SARS-CoV-2-induced pandemic wanes, a substantial number of
patients with acute Corona Virus-induced disease (COVID-19 continue to have symptoms …

Introduction The acute respiratory distress syndrome (ARDS) is a common complication of
severe COVID-19 and contributes to patient morbidity and mortality. ARDS is a …

Our study objective was to construct models using 20 routine laboratory parameters on
admission to predict disease severity and mortality risk in a group of 254 hospitalized COVID …

Background Chile was severely affected by COVID19 outbreaks but was also one of the first
countries to start a nationwide program to vaccinate against the disease. Furthermore, Chile …

Background: There is growing evidence of fungal infections associated with COVID-19. The
development of cryptococcosis in these patients has been infrequently reported. However, it …

Introduction There is a critical gap in understanding which SARS-CoV-2 patients would
benefit most from venovenous extracorporeal membrane oxygenation (VV-ECMO) support …

Introduction The emergence of SARS-CoV-2, which causes COVID-19, has led to over 400
million reported cases worldwide. COVID-19 disease ranges from asymptomatic infection to …